Navigation Links
New Cancer “Growth Blocking Super Drug” Patents Filed
Date:2/8/2013

San Diego, CA (PRWEB) February 08, 2013

The pharmaceutical world has been racing for the cure for cancer for decades with what most experts agree is limited success. The current drugs are either so toxic and damaging to the body that many patients have to weigh the benefits of their use or the drugs are only designed to treat specific types of cancers and often only specific “strains” of specific cancers.

There is now an emerging world class sprinter in the race to create the “Super Drug” – Kalos Therapeutics. The “Super Drug” in the cancer world refers to a drug that may be used to treat multiple types of cancer and their various strains while avoiding the additional trauma often caused by chemotherapy, radiation and many of the current cancer drugs.

Kalos Therapeutics is an emerging biomedical company with the exclusive patent to develop the ANP (Atrial Natriuretic Peptide) family of peptides as a new mechanism for the treatment of cancer.

Kalos is pioneering an approach to cancer treatment by developing peptides made primarily in the heart, as a cytostatic therapeutic for treating aggressive cancers by engaging known pathway receptors more efficiently without the side effects associated with chemotherapeutic or small molecule compounds.

George Colberg, the CEO of Kalos Therapeutics, has amassed a who’s who dream team representing the best and brightest of the cancer and bio-tech worlds. More importantly is the fact that the team has the ability to think differently about what is the most effective way to treat cancer. It is that difference in thinking that appears to be producing a game changing cancer therapy.

Anti-Cancer Bio-technology

“Kalos has successfully leveraged the natural antiproliferative activity of the Atrial Natriuretic Peptide (ANP) family of peptides in our pat
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. University of Colorado Cancer Center Review Shows Long-term Side-effects of New, Targeted Therapies in Pediatric Cancer Patients
2. Transcreener Assays Highlighted for Challenging Microbial, Cancer and Epigenetic Drug Targets at SLAS 2013
3. Governor Cuomo Announces Continued Growth at Roswell Park Cancer Institute with Regional Economic Development Council Funding; RPCI Center for Personalized Medicine established with CTG (NASDAQ: CTGX) serving as its technology partner
4. Transition in cell type parallels treatment response, disease progression in breast cancer
5. Two University of Colorado Cancer Center Studies Show that Silibinin, Found in Milk Thistle, Protects Against UV-Induced Skin Cancer
6. Navigating Cancer Announces Jeff Oberlander as VP, Engineering
7. Tracking the Battle Against Breast Cancer With New Market Research
8. Caris Life Sciences Adds Next-Generation Sequencing to Enhance Evidence-Based Tumor Profiling Service for Cancer Patients
9. WaferGens MyDesign Open Platform Facilitates Rapid Development of a Proprietary Prostate Cancer Diagnostic Panel in the Lab of Dr. Arul Chinnaiyan at the University of Michigan Cancer Center
10. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
11. DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Fla. , Aug. 26, 2014 ... under the symbol (NUUU) has two (2) wholly- ... Our two subsidiaries harness scientifically advanced technology to ... NUUU,s Renuell Int,l, Inc. is ... anti-aging skin care products that is made possible ...
(Date:8/26/2014)... , Aug. 26, 2014   Loveland Products, ... provider of high-performance crop input products and proprietary ... that the company has acquired a controlling interest ... agricultural biotechnology company delivering biochemical-based products for efficient ... Loveland Products, fastest growing plant nutrition brands, Accomplish ...
(Date:8/26/2014)... August 26, 2014 After searching ... core research facilities , the University of Kansas ... Center have chosen iLab Solutions' web-based core facility ... productivity. , "We are very pleased that ... Cancer Center signed on with us,” stated Heather ...
(Date:8/26/2014)... Talon Innovations, a provider of ... Medical Device, Aerospace and other technology-driven industries, announces today ... magazine’s fourth annual Manufacturing Award in the category of ... that Talon received a grant from the Minnesota Job ... training program for its employees. , Talon’s ...
Breaking Biology Technology:Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 2Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 3Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 4The University of Kansas Medical Center and The University of Kansas Cancer Center Select iLab Solutions Web-based Software to Streamline Operations 2The University of Kansas Medical Center and The University of Kansas Cancer Center Select iLab Solutions Web-based Software to Streamline Operations 3Talon Innovations Selected as Finalist for Minnesota Business Magazine Award 2Talon Innovations Selected as Finalist for Minnesota Business Magazine Award 3
... Switzerland and NUTLEY, N.J., Oct. 1 This ... leading business and,marketing publications, selected Roche out of ... Year." This marks the first time Roche has,received ... company,s focus on innovation-driven,healthcare as demonstrated by its ...
... 1 - New Product Under Development for ... in 28 European Countries DAIICHI SANKYO EUROPE GmbH ... new antihypertensive medication. It is a fixed combination,(CS-8663) of ... calcium antagonist Amlodipin. When approved, the new combination ...
... 1 Austria now has the most,consumer-friendly healthcare ... Consumer Index (EHCI). The EHCI compares all the ... Switzerland, from a,consumer-friendly point of view, measured by ... the Netherlands, with 2006 winner,France in third place. ...
Cached Biology Technology:Med Ad News Honors Roche as 'Company of the Year' 2Med Ad News Honors Roche as 'Company of the Year' 3DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin 2European Union has 'Three-Speed' Healthcare System - Many Countries Lagging in Reform 2
(Date:8/26/2014)... is pumping far more pollution into the atmosphere than ... the National Center for Atmospheric Research estimates that more ... in such fires, emitting gases and particles that can ... new study provides the first rough estimates, on a ... and mercury that are emitted by the fires. Such ...
(Date:8/26/2014)... Previous studies that have suggested an increased risk ... antidepressants during pregnancy may actually reflect the known ... In a study receiving advance online publication in ... Hospital (MGH) report that while a diagnosis ... the children of mothers prescribed antidepressants during pregnancy ...
(Date:8/26/2014)... Treatment of Animals (PETA) and the PETA International Science ... week at the 9th World Congress on Alternatives and ... on alternatives to the use of animals in research, ... problems with current laboratory oversight systems. , At the ... 28, 2014, PETA and PISC will present seven oral ...
Breaking Biology News(10 mins):Trash burning worldwide significantly worsens air pollution 2Trash burning worldwide significantly worsens air pollution 3Study calls into question link between prenatal antidepressant exposure and autism risk 2Study calls into question link between prenatal antidepressant exposure and autism risk 3
... of researchers from the LGC Chemical Metrology Laboratory in the ... up with a method to detect how the proportions of ... of protons and electrons but different numbers of neutrons) vary ... is to be able to use these methods to track ...
... have identified the locking mechanism that allows some neurons ... of genes that produce a critical cell-adhesion molecule involved ... The discovery -- captured with fluorescent imaging of excitatory ... studied in culture as they continued to develop -- ...
... (Nasdaq: AWRE ), a leading supplier of broadband ... first quarter ended March 31, 2009. Revenues for the ... 22% compared to $5.9 million in the same quarter last ... diluted net income per share in accordance with U.S. generally ...
Cached Biology News:Sulphur in just one hair could blow a terrorist's alibi 2Sulphur in just one hair could blow a terrorist's alibi 3Capturing the birth of a synapse 2Aware, Inc. Reports First Quarter 2009 Financial Results 2Aware, Inc. Reports First Quarter 2009 Financial Results 3Aware, Inc. Reports First Quarter 2009 Financial Results 4Aware, Inc. Reports First Quarter 2009 Financial Results 5Aware, Inc. Reports First Quarter 2009 Financial Results 6
... Western blotting is a commonly used ... Typically, protein samples are electrophoresed on SDS-PAGE ... nitrocellulose or nylon, where they are probed ... technologies, which allow reuse of Southern and ...
... ProXPRESS 2D Proteomic Imaging System, Basic Package ... a Wide Dynamic Range: The ProXPRESS 2D ... in imaging system for both proteomic and ... provides unparalleled flexibility, enabling the use of ...
... Introducing our Regulatory Edition of Molecular Imaging ... systems for life science research and drug ... compliance with U.S. Food and Drug Administrations ... 11 Electronic Records; Electronic Signatures [21 CFR ...
... OPA1-01009, OPEP-01009 is a 16 amino acid (amino acids 3-18) ... (DFF). The sequence of this peptide is (amino to ... S - V - K - L - R - ... R - K(18). This peptide may be used ...
Biology Products: